Goldenwell Biotech, Inc.
GWLL· OTC
GWLLGoldenwell Biotech, Inc.
Filed Apr 1, 2022 · 10-K · 91 days after period end · 0001477932-22-001951
| Metric | Q4 2021 | Q4 2020 | Q4 2019dderived from reported figures |
|---|---|---|---|
| Revenue | $2.70K | — | — |
| Net Income | -$29.54K | -$2.98K | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Goldenwell Biotech, Inc. · CIK 1800373 · Engraved from SEC EDGAR
ended Dec 31, 2021 · filed Apr 1, 2022 · 91 d after period end
